Funding for this research was provided by:
Horizon 2020 Framework Programme for Research and Innovation of the European Commission, through the RISCC Network (847845)
Received: 14 May 2021
Accepted: 30 July 2021
First Online: 30 August 2021
: Written informed consent for participation was obtained from all individual participants enrolled in VALHUDES. VALHUDES was approved by the central Ethics Committee of the University Hospital of Antwerp/University of Antwerp (B300201733869) and confirmed by the local Ethics Committees of the University Hospital of Brussels, Ghent, Liège and the Hospital of Tienen.
: Not applicable.
: H De Pauw, E Peeters and M Arbyn are supported by the RISCC Network funded by the Horizon 2020 Framework of DG Research and Innovation, European Commission, Brussels, Belgium (grant No. 847845). S Van Keer is supported by a junior postdoctoral fellowship of the Research Foundation – Flanders (FWO), Belgium (Grant Number: 1240220 N). A Vorsters is co-founder of Novosanis (Belgium), a spin-off company of the University of Antwerp, and was minority shareholder until January 2019. D Vanden Broeck is employed by AML, a commercial lab performing cervical cytology and HPV testing. All other authors declare no personal conflicts of interest.